These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 10412897)

  • 1. Effect of tacrine hydrochloride on hepatic drug metabolism.
    Danbury TC; Eccles M; Ford J; Roberts CJ
    Eur J Drug Metab Pharmacokinet; 1999; 24(1):91-6. PubMed ID: 10412897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
    Van Geel CA; Van Bezooijen CF
    Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes.
    Madden S; Woolf TF; Pool WF; Park BK
    Biochem Pharmacol; 1993 Jul; 46(1):13-20. PubMed ID: 8347124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
    St Peter JV; Abul-Hajj Y; Awni WM
    Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug use by demented and non-demented elderly people.
    Wills P; Claesson CB; Fratiglioni L; Fastbom J; Thorslund M; Winblad B
    Age Ageing; 1997 Sep; 26(5):383-91. PubMed ID: 9351483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of velnacrine on the mixed function oxidase system.
    Eccles MJ; Danbury TC; Ford JM; Roberts CJ
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):121-5. PubMed ID: 9248779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
    Sharer JE; Wrighton SA
    Drug Metab Dispos; 1996 Apr; 24(4):487-94. PubMed ID: 8801065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.
    Watkins PB; Zimmerman HJ; Knapp MJ; Gracon SI; Lewis KW
    JAMA; 1994 Apr; 271(13):992-8. PubMed ID: 8139084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.
    Spaldin V; Madden S; Pool WF; Woolf TF; Park BK
    Br J Clin Pharmacol; 1994 Jul; 38(1):15-22. PubMed ID: 7946932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine metabolism in the rat by three hepatic monooxygenases.
    Inaba T; Lucassen M; Kalow W
    Life Sci; 1980 Jun; 26(23):1977-83. PubMed ID: 7401910
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
    Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
    Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.